The innovative tool for editing genes has set its sights on sickle-cell anemia.
Joined with General Hospital of Massachusetts, the company will research cancer treatments.
Not everyone agrees that we should advance this study, but it has incredible medical possibilities.
It's proving to be one of the best years of the century, and we're barely halfway through.
This technique may be able to cure serious diseases, but how can we regulate it?
This could reveal more about disorders that affect social communication, like depression or schizophrenia.
Take a moment to be awed by CRISPR's 2017 success.
Another first for gene editing.
Gene editing is giving us better weapons in the fight against HIV.
We're on the cusp of a new era in disease prevention.
Over 200,000 people subscribe to our newsletter.
Sign in to join the conversation.